Genomtec Valuation

Is GMT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GMT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate GMT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate GMT's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GMT?

Key metric: As GMT barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for GMT. This is calculated by dividing GMT's market cap by their current book value.
What is GMT's PB Ratio?
PB Ratio	7.8x
Book	zł12.77m
Market Cap	zł99.00m

GMT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	43746.8x
Enterprise Value/EBITDA	-9.9x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does GMT's PB Ratio compare to its peers?

The above table shows the PB ratio for GMT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	20.9x
GX1 genXone	1.8x	n/a	zł24.5m
BER Bioerg Spólka Akcyjna	61.2x	n/a	zł13.8m
URT Urteste	4.4x	n/a	zł115.0m
RDG Read-Gene	16.1x	n/a	zł54.2m
GMT Genomtec	7.8x	n/a	zł99.0m

Price-To-Book vs Peers: GMT is expensive based on its Price-To-Book Ratio (7.8x) compared to the peer average (7.5x).

Price to Book Ratio vs Industry

How does GMT's PB Ratio compare vs other companies in the European Biotechs Industry?

24 Companies	Price / Book	Estimated Growth	Market Cap

24 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: GMT is expensive based on its Price-To-Book Ratio (7.8x) compared to the European Biotechs industry average (2.3x).

Price to Book Ratio vs Fair Ratio

What is GMT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GMT PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	7.8x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate GMT's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.